Aussie/Kiwi M&A/Events

Aussie/Kiwi M&A/Events

Probiotec (PBP AU): Trading Wide Ahead Of 29th May Shareholder Vote

Quiddity Research's avatar
Quiddity Research
Mar 27, 2024
∙ Paid
Share
  • On the 22 December 2023, drugs maker/packager group Probiotec Ltd (PBP AU) entered into a Scheme with Indonesia's Pyridam Farma (PYFA IJ).

  • Pyridam is offering Probiotec shareholders A$3.00/share (in cash, or a 19% premium to the undisturbed price). An interim dividend of A$0.035/share was also added (now gone ex).

  • The Scheme Booklet is now out. The Scheme Meeting will be held on the 29th May. The IE says terms are fair. I agree. Trading wide. Gross spread is 4.9%.

Keep reading with a 7-day free trial

Subscribe to Aussie/Kiwi M&A/Events to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Quiddity Investment Advisors
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture